Filed 3.4y ago· Jan 20, 2023
39 days to disclose
Christopher L. Jacobs
RHouseNew York-27
↓sold
Cogent Biosciences
COGT
$1K-$15K
+6.5% vs S&P 500
Trade dateDec 12, 2022
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–13 of 13
Filed 3.4y ago· Jan 20, 2023
39 days to discloseChristopher L. Jacobs
RHouseNew York-27
↓sold
Athira Pharma, Inc
ATHA
$1K-$15K
Trade dateDec 12, 2022
Athira Pharma
Filed 3.4y ago· Jan 20, 2023
39 days to discloseChristopher L. Jacobs
RHouseNew York-27
↓sold
Relmada Therapeutics
RLMD
$1K-$15K
+6.5% vs S&P 500
Trade dateDec 12, 2022
Filed 3.4y ago· Jan 20, 2023
39 days to discloseChristopher L. Jacobs
RHouseNew York-27
↑bought
Krystal Biotech
KRYS
$1K-$15K
+296.3% vs S&P 500
Trade dateDec 12, 2022
Filed 3.5y ago· Dec 12, 2022
34 days to discloseChristopher L. Jacobs
RHouseNew York-27
↓sold
Enochian Biosciences, Inc
ENOB
$1K-$15K
Trade dateNov 8, 2022
Enochian Biosciences
Filed 3.5y ago· Dec 12, 2022
34 days to discloseChristopher L. Jacobs
RHouseNew York-27
↓sold
Athira Pharma, Inc
ATHA
$1K-$15K
Trade dateNov 8, 2022
Athira Pharma
Filed 3.5y ago· Dec 12, 2022
34 days to discloseChristopher L. Jacobs
RHouseNew York-27
↑bought
Relmada Therapeutics
RLMD
$1K-$15K
+19.2% vs S&P 500
Trade dateNov 8, 2022
Filed 3.5y ago· Dec 12, 2022
34 days to discloseChristopher L. Jacobs
RHouseNew York-27
↓sold
Akero Therapeutics, Inc
AKRO
$1K-$15K
Trade dateNov 8, 2022
Akero Therapeutics
Filed 3.5y ago· Dec 12, 2022
34 days to discloseChristopher L. Jacobs
RHouseNew York-27
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+21.3% vs S&P 500
Trade dateNov 8, 2022
Filed 3.5y ago· Nov 16, 2022
35 days to discloseChristopher L. Jacobs
RHouseNew York-27
↑bought
Pfizer
PFE
$1K-$15K
−58.7% vs S&P 500
Trade dateOct 12, 2022
Filed 3.7y ago· Sep 9, 2022
53 days to disclose · 8 past 45-day windowChristopher L. Jacobs
RHouseNew York-27
↑bought
Enochian Biosciences, Inc
ENOB
$1K-$15K
Trade dateJul 18, 2022
Enochian Biosciences
Filed 3.7y ago· Sep 9, 2022
53 days to disclose · 8 past 45-day windowChristopher L. Jacobs
RHouseNew York-27
↓sold
Athira Pharma, Inc
ATHA
$1K-$15K
Trade dateJul 18, 2022
Athira Pharma
Filed 3.9y ago· Jul 28, 2022
42 days to discloseChristopher L. Jacobs
RHouseNew York-27
↑bought
Axsome Therapeutics
AXSM
$15K-$50K
+900.3% vs S&P 500
Trade dateJun 16, 2022
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Jan 20, 2023 3.4y ago | Christopher L. Jacobs RHouseNew York-27 | ↓sold | Cogent Biosciences COGT | Dec 12, 2022 39 days to disclose | Flat·+0.0% +6.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | Christopher L. Jacobs RHouseNew York-27 | ↓sold | Athira Pharma, Inc ATHA Athira Pharma | Dec 12, 2022 39 days to disclose | price pending | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | Christopher L. Jacobs RHouseNew York-27 | ↓sold | Relmada Therapeutics RLMD | Dec 12, 2022 39 days to disclose | Flat·+0.0% +6.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 20, 2023 3.4y ago | Christopher L. Jacobs RHouseNew York-27 | ↑bought | Krystal Biotech KRYS | Dec 12, 2022 39 days to disclose | Good buy·+$24.2K+302.8% +296.3% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | Christopher L. Jacobs RHouseNew York-27 | ↓sold | Enochian Biosciences ENOB Enochian Biosciences | Nov 8, 2022 34 days to disclose | price pending | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | Christopher L. Jacobs RHouseNew York-27 | ↓sold | Athira Pharma, Inc ATHA Athira Pharma | Nov 8, 2022 34 days to disclose | price pending | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | Christopher L. Jacobs RHouseNew York-27 | ↑bought | Relmada Therapeutics RLMD | Nov 8, 2022 34 days to disclose | Good buy·+$2.5K+31.0% +19.2% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | Christopher L. Jacobs RHouseNew York-27 | ↓sold | Akero Therapeutics AKRO Akero Therapeutics | Nov 8, 2022 34 days to disclose | price pending | $1K-$15K midpoint $8K |
Dec 12, 2022 3.5y ago | Christopher L. Jacobs RHouseNew York-27 | ↑bought | Johnson & Johnson JNJ | Nov 8, 2022 34 days to disclose | Good buy·+$2.6K+33.1% +21.3% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 16, 2022 3.5y ago | Christopher L. Jacobs RHouseNew York-27 | ↑bought | Pfizer PFE | Oct 12, 2022 35 days to disclose | Bad buy·−$3K-36.9% −58.7% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | Christopher L. Jacobs RHouseNew York-27 | ↑bought | Enochian Biosciences ENOB Enochian Biosciences | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |
Sep 9, 2022 3.7y ago | Christopher L. Jacobs RHouseNew York-27 | ↓sold | Athira Pharma, Inc ATHA Athira Pharma | Jul 18, 2022 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |
Jul 28, 2022 3.9y ago | Christopher L. Jacobs RHouseNew York-27 | ↑bought | Axsome Therapeutics AXSM | Jun 16, 2022 42 days to disclose | Good buy·+$300.3K+924.1% +900.3% vs S&P 500 | $15K-$50K midpoint $32.5K |